''BPSA,'' a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia1

By Mikolajczyk S.D.   Millar L.S.   Wang T.J.   Rittenhouse H.G.   Wolfert R.L.   Marks L.S.   Song W.   Wheeler T.M.   Slawin K.M.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 41-45

Elsevier

Access to resources Recommend Favorite

Results of transition zone biopsy in black and white men with suspected prostate cancer - racial differences in men without prostate cancer

By Fowler J.E.   Bigler S.A.   Kilambi N.K.   Land S.A.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 346-350

Elsevier

Access to resources Recommend Favorite

Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection

By Taneja S.S.   Tran K.   Lepor H.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 222-226

Elsevier

Access to resources Recommend Favorite

Tumour Grade, Proliferation, Apoptosis, Microvessel Density, p53, and bcl-2 in Prostate Cancers: Differences Between Tumours Located in the Transition Zone and in the Peripheral Zone

By Erbersdobler A.   Fritz H.   Schnoger S.   Graefen M.   Hammerer P.   Huland H.   Henke R.-P.  

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 40-46

Elsevier

Access to resources Recommend Favorite

Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?

By Abdel-Khalek Mohamed   Sheir Khaled   El-Baz Mahmoud   Ibrahiem El-Houssieny  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 1, 2005-02 ,pp. : 49-55

Informa Healthcare

Access to resources Recommend Favorite